Leading Corporate & Business development activity for the Precision Oncology business with remit for - M&A, Strategic Partnerships, Licensing, Corporate Venture Investments & Divestments. Focus Areas - Molecular Diagnostics and related Life Sciences Tools, Liquid Biopsy, Multi-omics approaches (DNA, RNA, Proteins, Methylation) integrated with AI/ML driven digital pathology image analysis - in cancer research & clinical care with applications in tumor subtyping, prognosis, and diagnosis. Mass Spec based Proteomics for biomarker discovery.Experience working cross-functionally with R&D, clinical, finance, legal, medical affairs and commercial organizations to formulate business development strategy and drive competitive initiatives.

Acquired by Exact Sciences Corp in Jan, 2021Liquid biopsy based Multi-cancer early detection diagnostics startup

Verily (Google X spin-out) is a subsidiary of Alphabet focused on life sciences and healthcare innovation. Verily forges deep collaborations across the entire healthcare ecosystem with - Leading Life Sciences, MedTech & Healthcare Delivery Systems. Leverage cross-functional expertise in novel Bio Engineered Devices, cutting edge AI/ML advances and software data management & analytics to deliver solutions in innovative partnership models.Sell-side Business development focused on - Sourcing, due diligence, valuation and negotiating strategic co-development partnerships.

Responsible for Sourcing, Evaluation and Negotiating partnerships that can drive inorganic revenue growth or collaboration on technology, anchored around promoting applications for Personalized & Precision Medicine in Life Sciences Research and Clinical markets (Oncology, Rare Diseases, Applied Genomics and Population Level Sequencing initiatives).Closely collaborate with leaders in Product Management and R&D to help define areas of partnership interest and executed a number of agreements covering a range of deal structures including - Acquisitions, Co-marketing, Co-development, Distribution, Divestments, Licensing, OEM, Research Collaboration and Supply agreements.Led partnership strategy to support the development and commercialization of the industry's largest cloud-based data analytics platform and IoT solution for genomics - the BaseSpace Suite, connecting over 5,000 DNA sequencing machines globally, 70,000+ users and processing tens of petabytes of streaming machine data. Responsible for partnership strategies that support the scientific and business objectives of Illumina Artificial Intelligence Lab's efforts in applying novel AI/deep learning algorithms to automate and accelerate genome data interpretation and generate actionable insights for clinical decision support and bio marker research purposes.

Part of the founding team that spun-out Veradigm from Allscripts. Responsible for new business creation - including conceptualizing, delivering and commercializing innovative data and analytics solutions that leverage Real World Evidence (RWE) data including Electronic Health Records (EHR) & Electronic Prescription data, to facilitate Pharma/Payer collaborations with Healthcare Providers around – patient engagement, care gaps identification, patient recruitment for clinical trials, medication adherence and population heath management.Responsible for developing a comprehensive strategy and business plan for Allscripts entry into the Telehealth space.

Led launch of Cisco's first Telehealth/Telemedicine solution (HealthPresence)Responsible for Product Strategy and Business Development activities for the Telehealth solutions portfolio.Led "Process Excellence" program team within the Global Supplier Management group.